As the spat continues over a proposed waiver of intellectual property rights on COVID-19 products, last week’s G7 meeting in the UK showed that other, more collaborative approaches could also aid efforts to ensure equitable access to coronavirus vaccines and medicines across the globe.
Following their in-person meeting in Oxford on 3-4 June, G7 health ministers signed up to a new agreement designed to...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?